PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES ...

May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.352
https://www.valueinhealthjournal.com/article/S1098-3015(11)00491-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 909
First Page : A62
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00491-8&doi=10.1016/j.jval.2011.02.352
HEOR Topics :
Tags :
Regions :